Brief: Metis Techbio HY Loss Attributable Rmb153.2 Million
25/08/2026 11:16
BRIEF-Metis Techbio HY Loss Attributable Rmb153.2 Million Aug 25 (Reuters) - Metis TechBio Co Ltd 7666.HK:
METIS TECHBIO CO LTD - HY LOSS ATTRIBUTABLE RMB153.2 MILLION
METIS TECHBIO CO - REVENUE FROM CONTRACTS WITH CUSTOMERS FOR SIX MONTHS ENDED JUNE 30, 2026 UP 13,399% TO RMB154.3 MILLION
Further company coverage: 7666.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metis TechBio
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
HK-listed Metis TechBio climbs on deal with Eli Lilly
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion (updated)
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech